JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, cilt.314, ss.1-6, 2017 (SCI İndekslerine Giren Dergi)
A large number of radiolabeled compounds have been studied to identify their potential as diagnostic and therapeutic tools in different cancer types. We reviewed several of our studies to give a perspective on Tc-99m and I-125/131 labeled receptor targeted compounds which are estrogen receptor targeted, anti estrogen receptor targeted, opioid receptor targeted and receptor-binding peptide and their bioaffinities by using in vitro/in vivo methods.